Assetmark Inc. Raises Holdings in Waters Corporation $WAT

Assetmark Inc. boosted its position in Waters Corporation (NYSE:WAT) by 440.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,645 shares of the medical instruments supplier’s stock after purchasing an additional 7,860 shares during the quarter. Assetmark Inc.’s holdings in Waters were worth $2,872,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC increased its holdings in shares of Waters by 543.8% in the fourth quarter. SG Americas Securities LLC now owns 37,244 shares of the medical instruments supplier’s stock valued at $14,146,000 after purchasing an additional 31,459 shares during the period. Banque Cantonale Vaudoise increased its stake in Waters by 329.0% in the 4th quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock valued at $1,631,000 after buying an additional 3,293 shares during the period. Nordea Investment Management AB increased its stake in Waters by 15.8% in the 4th quarter. Nordea Investment Management AB now owns 13,550 shares of the medical instruments supplier’s stock valued at $5,177,000 after buying an additional 1,848 shares during the period. Rockefeller Capital Management L.P. raised its position in Waters by 106.7% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,751 shares of the medical instruments supplier’s stock worth $1,045,000 after buying an additional 1,420 shares during the last quarter. Finally, M&T Bank Corp lifted its stake in shares of Waters by 1,662.4% in the 4th quarter. M&T Bank Corp now owns 64,273 shares of the medical instruments supplier’s stock worth $24,413,000 after acquiring an additional 60,626 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Up 3.1%

WAT stock opened at $382.38 on Friday. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average price is $364.32 and its 200 day moving average price is $345.93. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15. The company has a market cap of $37.55 billion, a P/E ratio of 48.59, a P/E/G ratio of 2.24 and a beta of 1.20.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The company had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same period last year, the company posted $2.25 earnings per share. The firm’s quarterly revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, research analysts expect that Waters Corporation will post 14.51 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WAT has been the topic of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a report on Friday, July 17th. UBS Group increased their price target on shares of Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their price objective on Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. TD Cowen reissued a “hold” rating on shares of Waters in a research note on Wednesday, July 15th. Finally, Piper Sandler started coverage on Waters in a research note on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price target on the stock. Three investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $401.60.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.